Novavax Inc (NVAX): Shares Outstanding

Annual figures by period end, from SEC filings.

162.58M
As of 2025-12-31
164.82M
As of 2026-06-30
+23.6%
3-year compound annual growth
+18.0%
5-year compound annual growth
-4.9%
10-year compound annual growth
323.23M2010-12-31: 111.04M2011-12-31: 117.03M2012-12-31: 147.94M2013-12-31: 208.66M2014-12-31: 238.83M2015-12-31: 269.97M2016-12-31: 271.25M2017-12-31: 323.23M2018-12-31: 19.22M2019-12-31: 32.35M2020-12-31: 70.95M2021-12-31: 75.84M2022-12-31: 86.04M2023-12-31: 139.51M2024-12-31: 160.42M2025-12-31: 162.58M162.58M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31162.58M+1.3%2026-02-26, Balance as of period end
2024-12-31160.42M+15.0%2026-02-26, Balance as of period end
2023-12-31139.51M+62.1%2025-02-27, Balance as of period end
2022-12-3186.04M+13.4%2024-02-28, Balance as of period end
2021-12-3175.84M+6.9%2023-02-28, Balance as of period end
2020-12-3170.95M+119.3%2022-03-01, Balance as of period end
2019-12-3132.35M+68.3%2021-03-01, Balance as of period end
2018-12-3119.22M-94.1%2020-03-11, Balance as of period end
2017-12-31323.23M+19.2%2019-03-18, Balance as of period end
2016-12-31271.25M+0.5%2018-03-14, Balance as of period end
2015-12-31269.97M+13.0%2017-02-27, Balance as of period end
2014-12-31238.83M+14.5%2016-02-29, Balance as of period end
2013-12-31208.66M+41.0%2015-02-27, Balance as of period end
2012-12-31147.94M+26.4%2014-03-12, Balance as of period end
2011-12-31117.03M+5.4%2013-03-12, Balance as of period end
2010-12-31111.04Mn/a2012-03-14, Balance as of period end